Intraday Alerts

Share SHARE

Dorman Products Inc. (DORM) reported second quarter EPS of $0.64 Wednesday morning, up from $0.53 a year ago. The consensus estimate was for EPS of $0.65. Dorman Products gapped open sharply lower Wednesday and is now down 5.12 at $43.20, with volume at over a 5-month high. The stock has plunged to...

DreamWorks Animation (DWA) reported a second quarter loss of $0.18 per share after the close Tuesday, compared to the profit of $0.26 per share last year. The consensus estimate was for a loss of $0.02 per share. DreamWorks Animation gapped open sharply lower Wednesday morning and is now down 3.09...

Humana Inc. (HUM) reported second quarter EPS of $2.19 Wednesday morning, down from $2.63 in the prior year period. Analysts had expected EPS of $2.19. The company continues to expect full year EPS of $7.25 to $7.75. The consensus estimate is for EPS of $7.84. Humana gapped open lower Wednesday and...

Rockwell Automation Inc. (ROK) reported third quarter adjusted EPS of $1.49 Wednesday morning, down from $1.54 in the previous year. Analysts expected EPS of $1.56. The company now expects to report full year adjusted EPS of $6.10 to $6.25, compared to prior expectations of $6.00 to $6.35. The consensus...

FTD Companies Inc. (FTD) announced Wednesday morning that it has agreed to acquire Liberty Interactive Corp.'s Provide Commerce floral and gifting businesses in a $430 million transaction. FTD Companies gapped open sharply higher Wednesday and is now up 4.46 at $34.00 in early trade. The stock has...

ZELTIQ Aesthetics Inc. (ZLTQ) reported second quarter EPS of $0.07 after the bell Tuesday, compared to the loss of $0.10 last year. The company also increased its full year 2014 revenue forecast to between $160 million and $165 million, from prior guidance of $137 million to $140 million. ZELTIQ Aesthetics...

Hess Corp. (HES) reported second quarter adjusted EPS of $1.38 Wednesday morning, compared to $1.51 a year ago. The consensus estimate was for EPS of $1.18. Hess gapped open sharply higher this morning and is now up 4.51 at $103.93. The stock has climbed above a 1-month range and has set a new high for the year.

Inphi Corp. (IPHI) announced Wednesday morning that it agreed to acquire Cortina Systems' High-Speed Interconnect and Optical Transport product lines for $52.5 million in cash and $73.5 million in stock. Inphi gapped up Wednesday and has risen sharply in early trade. The stock is now up 3.35 at $16.14...

Edwards Lifesciences Corp. (EW) reported second quarter adjusted EPS of $0.88 after the close Tuesday, up from $0.84 a year ago. Analysts expected EPS of $0.77. Third quarter adjusted EPS is expected to be between $0.66 and $0.72, compared to the consensus estimate of $0.74. The company also raised its...

Panera Bread Co. (PNRA) reported second quarter EPS of $1.82 after the bell Tuesday, up from $1.74 in the prior year period. The consensus estimate was for EPS of $1.74. The company expects to report third quarter EPS of $1.40 to $1.46 and between $6.65 and $6.80 for the full year. Analysts are expecting...

Amgen Inc. (AMGN) reported second quarter adjusted EPS of $2.37 after the close Tuesday, up from $1.89 a year ago. Analysts expected EPS of $2.07. Full year 2014 adjusted EPS is expected to be between $8.20 and $8.40. The consensus estimate is for EPS of $8.09. Amgen gapped open sharply higher Wednesday...

Buffalo Wild Wings (BWLD) reported second quarter EPS of $1.25 after the bell Tuesday, compared to $0.88 a year ago. The consensus estimate was for EPS of $1.20. Total revenue increased 20.0% to $366.0 million. Analysts were expecting EPS of $359.5 million. The company also stated that full year 2014...

Twitter Inc. (TWTR) reported second quarter adjusted EPS of $0.02 after the bell Tuesday, compared to the loss of $0.12 in the previous year. Analysts expected a loss of $0.01. Revenues rose 124% to $312.17 million from $139.29 million a year ago. The consensus estimate was for revenues of $283.07 million. The...

Regeneron Pharmaceuticals Inc. (REGN) and Sanofi (SNY) announced Wednesday morning that nine new Phase 3 ODYSSEY trials of alirocumab, in patients with hypercholesterolemia, met their primary efficacy endpoint of a greater percent reduction from baseline in low-density lipoprotein cholesterol at 24 weeks...

United Therapeutics Corp. (UTHR) reported second quarter non-GAAP EPS of $2.30 Tuesday morning, down from $2.38 last year. The consensus estimate was for EPS of $1.75. United Therapeutics gapped open higher Tuesday and has continued to rise steadily in early trade. The stock is now up 10.65 at $101.50...